A detailed history of Calamos Advisors LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Calamos Advisors LLC holds 14,464 shares of LGND stock, worth $1.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,464
Previous 10,847 33.35%
Holding current value
$1.64 Million
Previous $913,000 58.6%
% of portfolio
0.01%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$82.7 - $110.11 $299,125 - $398,267
3,617 Added 33.35%
14,464 $1.45 Million
Q2 2024

Jul 25, 2024

BUY
$68.53 - $87.91 $124,176 - $159,292
1,812 Added 20.06%
10,847 $913,000
Q1 2024

May 08, 2024

BUY
$68.64 - $89.2 $305,379 - $396,850
4,449 Added 97.01%
9,035 $660,000
Q4 2023

Jan 31, 2024

BUY
$49.57 - $72.63 $227,328 - $333,081
4,586 New
4,586 $327,000
Q2 2023

Jul 28, 2023

SELL
$69.53 - $79.33 $770,183 - $878,738
-11,077 Reduced 46.75%
12,619 $909,000
Q1 2023

May 03, 2023

BUY
$65.67 - $77.08 $510,518 - $599,219
7,774 Added 48.83%
23,696 $1.74 Million
Q4 2022

Jan 25, 2023

BUY
$61.72 - $96.74 $982,705 - $1.54 Million
15,922 New
15,922 $0
Q1 2019

Apr 12, 2019

SELL
$105.93 - $142.47 $162,072 - $217,979
-1,530 Closed
0 $0
Q3 2018

Oct 22, 2018

BUY
$211.18 - $274.49 $323,105 - $419,969
1,530 New
1,530 $420,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.